Table 2.

Adjusted CAC Volume and Density Among Those with DM or MetS

		DM (n = 668)	MetS (n = 1122)	Neither DM/MetS (n = 2028)	p value
CAC volume (95%CI)	Overall	79.46 (71.97–87.72)§	60.53 (55.46–66.08)‡	51.77 (48.01–55.82)	< 0.0001
	Non-statin users	72.17 (64.44–80.81)§	56.58 (51.72–61.89)*	48.61 (45.16–52.32)	< 0.0001
	Statin users	98.12 (80.60-119.44)§	69.32 (56.62–84.88)	57.24 (47.59–68.85)	< 0.0001
CAC density (95%CI)	Overall	2.54 (2.49–2.59)§	2.61 (2.57–2.65)‡	2.69 (2.65–2.72)	< 0.0001
	Non-statin users	2.56 (2.51–2.62)§	2.62 (2.57–2.66)†	2.68 (2.65–2.72)	0.0001
	Statin users	2.53 (2.44–2.62)§	2.65 (2.55–2.74)*	2.76 (2.67–2.84)	< 0.0001

The mean CAC density (or ln(Volume)) was adjusted for ln(Volume) (or CAC density), age, sex, race/ethnicity, education, smoking status, statin use and hypertension medication

P values were calculated from ANOVA test among three groups (last column) and from student t-tests comparing DM vs. neither DM/MetS and MetS versus neither DM/MetS (presented as symbols)

CAC  Coronary artery calcium, DM  Diabetes mellitus, MetS  Metabolic syndrome

*p < 0.05, †p < 0.01, ‡ p< 0.001, §p < 0.0001.